T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Lithia Motors
LAD
$8.32B
| $544K | ﹤0.01% |
7,660
+1,400
| +22% | +$112K |
|
1927
Universal Corp
UVV
$1.12B
| $543K | ﹤0.01% |
9,400
| – | – |
|
|
SF
1928
Stifel
SF
$12.9B
| $542K | ﹤0.01% |
38,759
| – | – |
|
|
GOV
1929
DELISTED
Government Properties Income Trust
GOV
| $542K | ﹤0.01% |
23,500
| – | – |
|
|
VTAE
1930
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $541K | ﹤0.01% |
50,156
| – | – |
|
1931
Ormat Technologies
ORA
$6.98B
| $538K | ﹤0.01% |
12,300
| – | – |
|
|
RGC
1932
DELISTED
Regal Entertainment Group
RGC
| $533K | ﹤0.01% |
24,175
-10
| -0% | -$208 |
|
1933
Winnebago Industries
WGO
$921M
| $532K | ﹤0.01% |
23,204
-16
| -0.1% | -$344 |
|
|
CYNO
1934
DELISTED
Cynosure, Inc. Class A
CYNO
| $531K | ﹤0.01% |
10,917
| – | – |
|
1935
Scansource
SCSC
$1.06B
| $530K | ﹤0.01% |
14,270
| – | – |
|
1936
Walker & Dunlop
WD
$1.47B
| $530K | ﹤0.01% |
23,270
-394,863
| -94% | -$9.24M |
|
|
TEF
1937
DELISTED
Telefonica
TEF
| $529K | ﹤0.01% |
71,762
-10,812
| -13% | -$86.8K |
|
|
WNR
1938
DELISTED
Western Refining Inc
WNR
| $528K | ﹤0.01% |
25,580
+3,040
| +13% | +$71.4K |
|
1939
FirstCash
FCFS
$9.14B
| $522K | ﹤0.01% |
10,170
+2,800
| +38% | +$130K |
|
1940
The RMR Group
RMR
$346M
| $522K | ﹤0.01% |
16,855
| – | – |
|
|
TCF
1941
DELISTED
TCF Financial Corporation Common Stock
TCF
| $520K | ﹤0.01% |
13,951
-8,200
| -37% | -$311K |
|
1942
AAR Corp
AIR
$5.77B
| $518K | ﹤0.01% |
22,190
+2,400
| +12% | +$57K |
|
|
ARI
1943
Apollo Commercial Real Estate
ARI
$886M
| $513K | ﹤0.01% |
31,945
+9,622
| +43% | +$154K |
|
|
LMNX
1944
DELISTED
Luminex Corp
LMNX
| $512K | ﹤0.01% |
25,300
+8,300
| +49% | +$166K |
|
|
TPC
1945
Tutor Perini Cor
TPC
$4.98B
| $511K | ﹤0.01% |
21,700
-3,400
| -14% | -$66.3K |
|
1946
Designer Brands
DBI
$312M
| $510K | ﹤0.01% |
24,072
-117,245
| -83% | -$2.7M |
|
1947
Sonida Senior Living
SNDA
$1.88B
| $510K | ﹤0.01% |
1,926
+199
| +12% | +$56K |
|
1948
Upbound Group
UPBD
$1.15B
| $510K | ﹤0.01% |
41,540
+7,500
| +22% | +$101K |
|
1949
Evercore
EVR
$12B
| $509K | ﹤0.01% |
11,522
+32
| +0.3% | +$1.59K |
|
1950
CBIZ
CBZ
$2.96B
| $508K | ﹤0.01% |
48,775
+10,612
| +28% | +$109K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.